BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29126878)

  • 1. Dendritic cells in systemic sclerosis: Advances from human and mice studies.
    Affandi AJ; Carvalheiro T; Radstake TRDJ; Marut W
    Immunol Lett; 2018 Mar; 195():18-29. PubMed ID: 29126878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into dendritic cells in the pathogenesis of systemic sclerosis.
    Carvalheiro T; Zimmermann M; Radstake TRDJ; Marut W
    Clin Exp Immunol; 2020 Jul; 201(1):25-33. PubMed ID: 31970748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL4-RNA Complexes Circulate in Systemic Sclerosis and Amplify Inflammatory/Pro-Fibrotic Responses by Myeloid Dendritic Cells.
    Pietraforte I; Butera A; Gaddini L; Mennella A; Palazzo R; Campanile D; Stefanantoni K; Riccieri V; Lande R; Frasca L
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis.
    Lande R; Lee EY; Palazzo R; Marinari B; Pietraforte I; Santos GS; Mattenberger Y; Spadaro F; Stefanantoni K; Iannace N; Dufour AM; Falchi M; Bianco M; Botti E; Bianchi L; Alvarez M; Riccieri V; Truchetet ME; C L Wong G; Chizzolini C; Frasca L
    Nat Commun; 2019 May; 10(1):1731. PubMed ID: 31043596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature.
    Lande R; Mennella A; Palazzo R; Pietraforte I; Stefanantoni K; Iannace N; Butera A; Boirivant M; Pica R; Conrad C; Chizzolini C; Riccieri V; Frasca L
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8.
    Ah Kioon MD; Tripodo C; Fernandez D; Kirou KA; Spiera RF; Crow MK; Gordon JK; Barrat FJ
    Sci Transl Med; 2018 Jan; 10(423):. PubMed ID: 29321259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances.
    Laurent P; Sisirak V; Lazaro E; Richez C; Duffau P; Blanco P; Truchetet ME; Contin-Bordes C
    Front Immunol; 2018; 9():1702. PubMed ID: 30083163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunopathogenesis of fibrosis in systemic sclerosis.
    Brown M; O'Reilly S
    Clin Exp Immunol; 2019 Mar; 195(3):310-321. PubMed ID: 30430560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights on the role of the innate immune system in systemic sclerosis.
    York MR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.
    Ottria A; Zimmermann M; Paardekooper LM; Carvalheiro T; Vazirpanah N; Silva-Cardoso S; Affandi AJ; Chouri E; V D Kroef M; Tieland RG; Bekker CPJ; Wichers CGK; Rossato M; Mocholi-Gimeno E; Tekstra J; Ton E; van Laar JM; Cossu M; Beretta L; Garcia Perez S; Pandit A; Bonte-Mineur F; Reedquist KA; van den Bogaart G; Radstake TRDJ; Marut W
    Rheumatology (Oxford); 2022 May; 61(6):2682-2693. PubMed ID: 34559222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?
    van Bon L; Cossu M; Scharstuhl A; Pennings BW; Vonk MC; Vreman HJ; Lafyatis RL; van den Berg W; Wagener FA; Radstake TR
    Rheumatology (Oxford); 2016 Nov; 55(11):2066-2073. PubMed ID: 27411481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.
    van Bon L; Affandi AJ; Broen J; Christmann RB; Marijnissen RJ; Stawski L; Farina GA; Stifano G; Mathes AL; Cossu M; York M; Collins C; Wenink M; Huijbens R; Hesselstrand R; Saxne T; DiMarzio M; Wuttge D; Agarwal SK; Reveille JD; Assassi S; Mayes M; Deng Y; Drenth JP; de Graaf J; den Heijer M; Kallenberg CG; Bijl M; Loof A; van den Berg WB; Joosten LA; Smith V; de Keyser F; Scorza R; Lunardi C; van Riel PL; Vonk M; van Heerde W; Meller S; Homey B; Beretta L; Roest M; Trojanowska M; Lafyatis R; Radstake TR
    N Engl J Med; 2014 Jan; 370(5):433-43. PubMed ID: 24350901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for IL-17 in the pathogenesis of systemic sclerosis?
    Chizzolini C; Dufour AM; Brembilla NC
    Immunol Lett; 2018 Mar; 195():61-67. PubMed ID: 28919455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell recruitment and activation in autoimmunity.
    Sozzani S; Del Prete A; Bosisio D
    J Autoimmun; 2017 Dec; 85():126-140. PubMed ID: 28774715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma.
    Chen M; Dittmann A; Kuhn A; Ruzicka T; von Mikecz A
    Arthritis Rheum; 2005 Mar; 52(3):877-84. PubMed ID: 15751092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages in Systemic Sclerosis: Novel Insights and Therapeutic Implications.
    Toledo DM; Pioli PA
    Curr Rheumatol Rep; 2019 May; 21(7):31. PubMed ID: 31123840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
    Ottria A; Hoekstra AT; Zimmermann M; van der Kroef M; Vazirpanah N; Cossu M; Chouri E; Rossato M; Beretta L; Tieland RG; Wichers CGK; Stigter E; Gulersonmez C; Bonte-Mineur F; Berkers CR; Radstake TRDJ; Marut W
    Front Immunol; 2020; 11():822. PubMed ID: 32528464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances on pathogenesis and therapies in systemic sclerosis.
    Yazawa N; Fujimoto M; Tamaki K
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):107-12. PubMed ID: 18064573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.